Emergent Executive and Leadership Team

Kelvin Lim, the President - ESMS at Emergent, drives the strategic direction and operational execution for the company's Emergent Services and Manufacturing Solutions (ESMS) division. Overseeing contract development and manufacturing services, Lim ensures the efficient production and delivery of critical medical countermeasures and pharmaceutical products for Emergent and its partners. This leadership role involves managing complex manufacturing processes, maintaining rigorous quality standards, and fostering strong client relationships to support the supply of vital treatments like Anthrasil and Ebanga. By optimizing manufacturing capabilities and supply chain resilience, Kelvin Lim directly contributes to Emergent's ability to meet urgent public health demands. Lim's focus on operational excellence solidifies Emergent's capacity as a reliable provider of life-saving solutions.

Michelle Pepin, the Chief Human Resources Officer at Emergent, directs all human capital strategies and organizational development initiatives. Overseeing talent acquisition, employee engagement, and compensation structures, Pepin ensures Emergent cultivates a high-performance culture aligned with its mission to address public health threats. This leadership role involves fostering an environment that supports scientific advancement and operational readiness across the company's diverse product portfolio, including vaccines and therapeutics for anthrax, cholera, and opioid overdose. By optimizing workforce planning and development, Michelle Pepin directly contributes to the company's capacity to deliver life-saving solutions. Pepin's strategic oversight extends to ensuring compliance and promoting ethical practices throughout the global workforce, reinforcing Emergent's commitment to preparedness and response.

Howard Anderson, the Senior Vice President and Chief Information Officer at Emergent, architects and executes the company's global information technology strategy. Overseeing all aspects of digital infrastructure, cybersecurity, and data management, Anderson ensures robust and secure systems that support Emergent's critical operations in developing and manufacturing medical countermeasures. This leadership position involves driving technological innovation to enhance research and development processes, streamline supply chain logistics for products like NARCAN Nasal Spray and BioThrax, and maintain compliance with stringent regulatory requirements. By implementing advanced IT solutions, Howard Anderson directly enables the company's mission to provide preparedness and response solutions for public health threats. Anderson's focus on digital transformation strengthens Emergent's ability to respond effectively to accidental, deliberate, and naturally occurring health crises.

Simon Lowry, the Chief Medical Officer Head of Research & Development at Emergent, spearheads the company's scientific innovation and product pipeline development. Overseeing all research and development activities, Lowry directs the discovery, preclinical, and clinical evaluation of novel therapeutics and vaccines designed to combat public health threats, including anthrax, cholera, and Ebola. This critical role involves translating scientific insights into tangible solutions, such as Vaxchora, Vivotif, and TEMBEXA, ensuring their efficacy and safety for market readiness. By guiding the R&D teams, Simon Lowry directly advances Emergent's commitment to addressing unmet medical needs and enhancing global health security. Lowry's leadership ensures a robust pipeline of countermeasures, reinforcing Emergent's position as a leader in biodefense and public health preparedness.